PURPOSE: Phase angle (PA), determined by bioelectrical impedance analysis (BIA), has been considered as a prognostic factor in several clinical conditions. The purpose of this study is to investigate PA, after adjusting for sex and age (standardized phase angle; SPA) as a prognostic factor for survival in cancer patients. METHODS: A prospective study was conducted in 195 patients before the first chemotherapy course. BIA was performed in all patients and SPA was calculated. The Kaplan-Meier method was used to calculate survival. The Cox regression method was used to evaluate the independent prognostic effect of PA after adjustment for other variables. RESULTS: Patients with SPA < -1.65 had a smaller survival rate than those with SPA ≥ -1.65 (p < 0.001). Using Cox regression, the mortality rate was higher in patients with SPA < -1.65 (RR 3.12 CI: 2.03-4.79; p < 0.001). After multivariate analysis, patients with PA < -1.65 still presented a higher mortality rate (RR 2.35 CI: 1.41-3.90; p = 0.001). CONCLUSIONS: The present study demonstrates that PA, used as SPA, is an independent prognostic indicator in this group of cancer patients receiving chemotherapy treatment even after adjustment for other prognostic variables.
<span class="abstract_title">PURPOSE: Phase angle (PA), determined by bioelectrical impedance analysis (BIA), has been considered as a prognostic factor in several clinical conditions. The purpose of this study is to investigate PA, after adjusting for sex and age (standardized phase angle; <span class="Gene">SPA) as a prognostic factor for survival in cancerpatients. METHODS: A prospective study was conducted in 195 patients before the first chemotherapy course. BIA was performed in all patients and SPA was calculated. The Kaplan-Meier method was used to calculate survival. The Cox regression method was used to evaluate the independent prognostic effect of PA after adjustment for other variables. RESULTS:Patients with SPA < -1.65 had a smaller survival rate than those with SPA ≥ -1.65 (p < 0.001). Using Cox regression, the mortality rate was higher in patients with SPA < -1.65 (RR 3.12 CI: 2.03-4.79; p < 0.001). After multivariate analysis, patients with PA < -1.65 still presented a higher mortality rate (RR 2.35 CI: 1.41-3.90; p = 0.001). CONCLUSIONS: The present study demonstrates that PA, used as SPA, is an independent prognostic indicator in this group of cancerpatients receiving chemotherapy treatment even after adjustment for other prognostic variables.
Authors: Maria Cristina G Barbosa-Silva; Aluísio J D Barros; Cora L A Post; Dan L Waitzberg; Steven B Heymsfield Journal: Nutrition Date: 2003-05 Impact factor: 4.008
Authors: Ursula G Kyle; Ingvar Bosaeus; Antonio D De Lorenzo; Paul Deurenberg; Marinos Elia; José Manuel Gómez; Berit Lilienthal Heitmann; Luisa Kent-Smith; Jean-Claude Melchior; Matthias Pirlich; Hermann Scharfetter; Annemie M W J Schols; Claude Pichard Journal: Clin Nutr Date: 2004-10 Impact factor: 7.324
Authors: Digant Gupta; Christopher G Lis; Sadie L Dahlk; Pankaj G Vashi; James F Grutsch; Carolyn A Lammersfeld Journal: Br J Nutr Date: 2004-12 Impact factor: 3.718
Authors: Digant Gupta; Carolyn A Lammersfeld; Jessica L Burrows; Sadie L Dahlk; Pankaj G Vashi; James F Grutsch; Sara Hoffman; Christopher G Lis Journal: Am J Clin Nutr Date: 2004-12 Impact factor: 7.045
Authors: G M Chertow; E G Lowrie; D W Wilmore; J Gonzalez; N L Lew; J Ling; M S Leboff; M N Gottlieb; W Huang; B Zebrowski Journal: J Am Soc Nephrol Date: 1995-07 Impact factor: 10.121
Authors: Romina L Barritta de Defranchi; Andrea Bordalejo; Inés Cañueto; Angeles Villar; Elizabet Navarro Journal: Support Care Cancer Date: 2014-10-28 Impact factor: 3.603
Authors: Steven B Heymsfield; Michael Adamek; M Cristina Gonzalez; Guang Jia; Diana M Thomas Journal: J Cachexia Sarcopenia Muscle Date: 2014-02-15 Impact factor: 12.910